Cream4349

Cream4349

Key Levels: - Key Level of 6.75 - If key level can hold support my next resistance target is 6.9 then 7.25 followed by a push to 8 - If key level cannot hold support my next bounce area is 6.55 near the daily 50ema - Earnings Released with increased forecast and revenue numbers. - Broke 7 in AH, looking for another break of 7 for more upside tomorrow. - Small...

Cream4349

Key Levels: Key Level of 5 - If key level can hold support i'm looking for next resistance targets at 5.5 then 6 - If key level cannot hold support my next bounce area is the daily 200ema at 4.9 - Stock breakout out of major resistance at 5 today. - Look for more upside into resistance then a possible short scalp or short swing to retest 5. - If we get a...

Cream4349

Watch for a bounce off 11k if we can hold 11k then we will break 13.4 and go all the way to 15k. If this happens we can break 20k this year!! Lets see if i'm right.

Cream4349

NKTR is a bio-pharmaceutical company that has a large pipeline. News: July 25th FDA issues letter postponing a Advisory Committee meeting (ADCOM) on their pain relief drug, the postponement is not related to the specific drug itself price drops. Aug 1st: Breakthrough Therapy Designation given for metastatic melanoma drug Aug 8th Earnings Report - expect a sell...

Cream4349

I bought XERS initially at 9.23 and have since then swung it from 11.50 to 12.50+ area. I believe it is heading into a short term bear trend which will precipitate a run up to the FDA PDUFA approval of it's diabetic non inject able. Short ratio is up as well. I marked the resistance and support points that I think are major. There are no triangles to work off of...

Cream4349

Ascending triangle. Looking for break out of 2.50 to start run heading into Aug 19th PDUFA. See chart for resistance/support points. GLTA!! I'm in at 2.40 with 1/3 of total position.

Cream4349 Updated 

$KALA $LABU $LABD This is my first published idea on Tradingview. I play biotech and pdufa run up and data releases. KALA has a pdufa aug 15th, based on the chart it looks to be heading into a bullish run into possible FDA approval. I made three resistance points to watch out based on the 50 and 200 moving averages as well as prior resistance points. GLTA!!!...